Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,363 shares at $53.99 ($74K) on 2008-02-29, disclosed to the SEC on 2008-03-04.
Scheduled sale ($74k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.99 | 334 | $18K | 24.4% |
| 2 | $54.22 | 1,029 | $56K | 75.6% |
| Total | $54.16 avg | 1,363 | $74K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |